Sector: Healthcare
Showing 1–100 of 6149 stocks (page 1 of 62).
| Stock | Market Cap | Dividend Yield | P/E Ratio | Dividend Frequency | Years Paying | DGR |
|---|---|---|---|---|---|---|
| 0R29.L Intuitive Surgical, Inc. | 5.5 trillion | 0.00% | 100.98 | - | - | - |
| 0KW4.L ResMed Inc. | 3.1 trillion | 0.72% | 43.86 | 4 | 9 | 8% |
| 0KSX.L Quest Diagnostics Incorporated | 2.7 trillion | 1.40% | 16.02 | 4 | 10 | 6% |
| LLY Eli Lilly and Company Contenders | 1.3 trillion | 0.47% | 46.01 | 4 | 55 | 16% |
| LLY.DE Eli Lilly and Company | 1.3 trillion | 0.54% | 48.09 | 4 | 11 | 12% |
| 0JZ2.L Masimo Corporation | 933.7 billion | 0.00% | 0.45 | - | - | - |
| LLY.SW LILLY ELI | 910.3 billion | 0.75% | 75.02 | 2 | - | - |
| JNJ.DE Johnson & Johnson | 616.4 billion | 0.56% | 40.26 | 4 | 27 | 2% |
| JNJ Johnson & Johnson Champions | 615.9 billion | 0.51% | 38.78 | 4 | 26 | 5% |
| JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG | 606.7 billion | 15.36% | 23.50 | 4 | 4 | - |
| JNJ.TO Johnson & Johnson | 571.2 billion | 2.10% | 29.68 | 4 | 1 | - |
| 4AB.DE AbbVie Inc. | 524.9 billion | 0.67% | 52.91 | 4 | 11 | 0% |
| ABBV AbbVie Inc. Contenders | 521.1 billion | 0.59% | 50.67 | 4 | 14 | 6% |
| ABBV.BA AbbVie Inc. | 494.0 billion | 2.07% | 10.31 | 4 | 6 | 30% |
| 0QCV.IL AbbVie Inc. | 463.0 billion | 2.61% | 51.23 | 4 | 6 | 5% |
| ABBV.NE AbbVie Inc. | 455.7 billion | 17.97% | 192.11 | 3 | 4 | - |
| NOVC.DE Novo Nordisk A/S | 392.6 billion | 1.06% | 22.93 | 2 | 22 | 12% |
| 0QQ6.L Roche Holding AG | 379.8 billion | 2.64% | 22.66 | 1 | 12 | 1% |
| 6MK.DE Merck & Co., Inc. | 371.3 billion | 2.54% | 158.02 | 4 | 27 | 2% |
| 0I3I.L The Cooper Companies, Inc. | 370.6 billion | 0.00% | 0.03 | - | - | - |
| MRK Merck & Co., Inc. Contenders | 368.9 billion | 2.27% | 118.67 | 4 | 65 | 6% |
| UNH.BA UNITEDHEALTH GROUP INC CEDEAR E | 361.6 billion | 0.00% | 251 | - | - | - |
| UNH UnitedHealth Group Incorporated Contenders | 360.3 billion | 0.54% | 25.82 | 4 | 37 | 12% |
| UNH.DE UnitedHealth Group Incorporated | 358.7 billion | 0.60% | 26.75 | 4 | 19 | 10% |
| RHHVF Roche Holding AG | 349.5 billion | 2.50% | 21.83 | 1 | 37 | 26% |
| RHHBF Roche Holding AG | 340.7 billion | 2.90% | 23.47 | 2 | 25 | 26% |
| RO.SW Roche Holding AG | 338.6 billion | 3.04% | 21.99 | 1 | 32 | 1% |
| RHHBY Roche Holding AG | 334.7 billion | 2.95% | 22.25 | 1 | 34 | 4% |
| UNH.NE UnitedHealth Group Inc | 315.9 billion | 2.46% | 14.66 | 4 | 5 | 30% |
| AZNCF AstraZeneca PLC | 312.8 billion | 1.56% | 33.46 | 3 | 18 | 24% |
| ROG.SW Roche Holding AG | 311.3 billion | 3.06% | 20.11 | 1 | 32 | 1% |
| NVS Novartis AG Challengers | 303.7 billion | 2.95% | 30.69 | 1 | 30 | 6% |
| NOVN.SW Novartis AG | 301.5 billion | 3.49% | 31.54 | 1 | 30 | 4% |
| AZN AstraZeneca PLC | 289.5 billion | 1.85% | 26.40 | 2 | 34 | 2% |
| AZN.ST AstraZeneca PLC | 284.1 billion | 0.19% | 27.10 | 2 | 27 | 4% |
| ZEG.DE AstraZeneca PLC | 279.2 billion | 2.00% | 29.17 | 1 | 26 | 6% |
| NVSEF Novartis AG | 257.0 billion | 2.91% | 25.97 | 2 | 30 | 5% |
| TMO Thermo Fisher Scientific Inc. Challengers | 253.2 billion | 0.06% | 36.12 | 4 | 15 | 14% |
| TMO.TO Thermo Fisher Scientific Inc. | 252.5 billion | 0.07% | 33.17 | - | - | - |
| 0R0H.L Thermo Fisher Scientific Inc. | 250.0 billion | 0.27% | 35.18 | 4 | 10 | 14% |
| TN8.DE Thermo Fisher Scientific Inc. | 245.4 billion | 0.27% | 28.60 | 4 | 10 | 12% |
| SRTOY Sartorius Stedim Biotech S.A. | 236.2 billion | 0.34% | 59.31 | 1 | 6 | -30% |
| TMO.NE Thermo Fisher Scientific Inc. | 217.7 billion | 0.30% | 28.54 | 4 | 3 | - |
| AMGN Amgen Inc. Contenders | 217.5 billion | 2.47% | 25.51 | 4 | 16 | 8% |
| AMG.DE Amgen Inc. | 217.2 billion | 2.41% | 25.58 | 4 | 16 | 4% |
| GIS.DE Gilead Sciences, Inc. | 214.5 billion | 2.25% | - | 4 | 12 | -1% |
| GILD.TO Gilead Sciences, Inc. | 212.2 billion | 0.97% | - | - | - | - |
| GILD Gilead Sciences, Inc. Contenders | 211.8 billion | 0.00% | - | 4 | 12 | 2% |
| NOVO-B.CO Novo Nordisk A/S | 202.2 billion | 3.82% | 11.79 | 2 | 27 | 2% |
| ABT.SW Abbott Laboratories | 189.7 billion | 1.99% | 34.62 | 3 | 26 | 14% |
| ABT Abbott Laboratories Contenders | 181.5 billion | 2.43% | 38.99 | 4 | 44 | 8% |
| ABL.DE Abbott Laboratories | 179.7 billion | 2.70% | 39.95 | 4 | 19 | 5% |
| NVS.TO Novartis AG | 174.4 billion | 14.78% | 30.96 | - | - | - |
| NVO Novo Nordisk A/S | 165.7 billion | 3.12% | 11.67 | 2 | 45 | 26% |
| NOV.DE Novo Nordisk A/S | 164.8 billion | 4.72% | 11.81 | 2 | 25 | 6% |
| NONOF Novo Nordisk A/S | 164.8 billion | 4.85% | 11.58 | 2 | 18 | 27% |
| DAP.DE Danaher Corporation | 164.1 billion | 0.73% | 39.15 | 5 | 24 | 9% |
| DHR Danaher Corporation Contenders | 163.8 billion | 0.66% | 38.57 | 4 | 34 | 14% |
| ISRG Intuitive Surgical, Inc. | 159.8 billion | 0.00% | 54.69 | - | - | - |
| PFE Pfizer Inc. Contenders | 156.2 billion | 6.28% | 35.21 | 4 | 55 | 2% |
| 0R2B.L Danaher Corporation | 152.1 billion | 0.66% | 26.40 | 4 | 11 | 30% |
| PFE.NE Pfizer Inc. | 147.8 billion | 6.23% | 14.81 | 4 | 5 | 4% |
| 0R2S.L Stryker Corporation | 146.7 billion | 0.28% | 55.80 | 4 | 11 | 6% |
| PFE.DE Pfizer Inc. | 145.6 billion | 6.43% | 19.53 | 4 | 27 | 0% |
| PFE.F Pfizer Inc. | 143.8 billion | 7.56% | 19.41 | 4 | 17 | 1% |
| IUI1.DE Intuitive Surgical, Inc. | 142.1 billion | 0.00% | 45.89 | - | - | - |
| PFE.BA Pfizer Inc. | 140.5 billion | 0.00% | 2.62 | 4 | 19 | 30% |
| 0Y6X.L Medtronic plc | 129.7 billion | 2.93% | 25.90 | 4 | 13 | 10% |
| BRM.DE Bristol-Myers Squibb Company | 128.7 billion | 1.16% | 14.48 | 4 | 28 | 2% |
| BMY Bristol-Myers Squibb Company Contenders | 127.7 billion | 1.03% | 13.85 | 4 | 55 | 5% |
| VRTX Vertex Pharmaceuticals Incorporated | 127.5 billion | 0.00% | 28.91 | - | - | - |
| 0QZU.L Vertex Pharmaceuticals Incorporated | 127.2 billion | 0.00% | 47.90 | - | - | - |
| FSNUY Fresenius SE & Co. KGaA | 122.2 billion | 2.25% | 16.96 | 1 | 2 | - |
| 0R1F.IL Bristol-Myers Squibb Company | 120.6 billion | 4.27% | 17.23 | 4 | 6 | 5% |
| SNYNF SANOFI | 118.6 billion | 4.07% | 24.26 | 1 | 17 | 2% |
| CSLLY CSL Limited | 118.3 billion | 2.37% | 8.20 | 2 | 18 | 8% |
| ANTM Anthem, Inc. | 117.1 billion | 0.85% | 25.82 | 1 | 13 | 14% |
| ISRG.TO Intuitive Surgical, Inc. | 116.6 billion | 0.00% | 55.70 | - | - | - |
| VX1.DE Vertex Pharmaceuticals Incorporated | 115.6 billion | 0.00% | 31.29 | - | - | - |
| CVS.DE CVS Health Corp. | 114.9 billion | 2.90% | 58.34 | 4 | 10 | 2% |
| 2M6.DE Medtronic plc | 113.0 billion | 3.10% | 25.49 | 5 | 19 | -2% |
| SYK Stryker Corporation Champions | 111.9 billion | 0.00% | 30.24 | 4 | 34 | 6% |
| CVS CVS Health Corp. | 111.0 billion | 3.06% | 25.24 | 4 | 42 | 6% |
| 0JZU.L McKesson Corporation | 110.6 billion | 0.38% | 136.66 | 4 | 10 | 13% |
| MDT Medtronic plc Champions | 110.6 billion | 3.31% | 23.19 | 4 | 45 | 3% |
| 0HRS.L CVS Health Corporation | 109.3 billion | 2.96% | 14.81 | 4 | 10 | 6% |
| SNW.DE Sanofi | 107.4 billion | 0.00% | 23.12 | 1 | 27 | 4% |
| CVS.NE CVS Health Corporation | 107.3 billion | 13.18% | 228.33 | 3 | 4 | - |
| SAN.PA Sanofi | 107.1 billion | 0.00% | 23.05 | 1 | 27 | 4% |
| SNY Sanofi | 106.2 billion | 0.00% | 22.06 | 1 | 24 | 4% |
| MCK McKesson Corporation Contenders | 105.6 billion | 0.38% | 23.58 | 4 | 40 | 14% |
| ESLOF ESSILORLUXOTTICA | 102.1 billion | 0.02% | 42.04 | 1 | 16 | 25% |
| GSK GSK plc | 99.2 billion | 3.67% | 17.25 | 4 | 43 | -6% |
| GLAXF GSK plc | 98.2 billion | 3.18% | 16.90 | 8 | 23 | 10% |
| HCA HCA Healthcare, Inc. | 97.7 billion | 0.65% | 15.70 | 4 | 9 | 20% |
| 0J1R.L HCA Healthcare, Inc. | 96.2 billion | 0.66% | 21.98 | 4 | 9 | 20% |
| REGN Regeneron Pharmaceuticals, Inc. | 96.0 billion | 0.11% | 20.51 | 4 | 2 | - |
| ELV Elevance Health Inc. Contenders | 93.5 billion | 1.56% | 18.32 | 4 | 20 | 12% |
| 0HG8.L Elevance Health, Inc. | 86.2 billion | 1.60% | 17.06 | 4 | 10 | 12% |
| CGN.DE The Cigna Group | 85.7 billion | 1.79% | 15.96 | 2 | 1 | - |